TIE2 protein emerges as potential drug target to prevent development of dangerous blood vessel defects in brain

Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a cell surface receptor protein called TIE2 as the missing link between two key signaling pathways that drive the growth of blood vessel abnormalities known as cerebral cavernous malformations (CCMs).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup